[ad_1] The Russian Sovereign Wealth Fund and Gamaleia Research Institute praised, in a statement, as well as their competition, the efficacy of the randomized and double-blind Sputnik-V vaccine – an experimental approach used in several disciplines – on a number of 40,000 volunteers. “Statistical analysis of 20 confirmed cases with …
Read More »Russia does not give up and relaunches the race for the COVID-19 vaccine: efficiency declared in the case of Sputnik V three days after the announcement of Pfizer and BioNTech
